Daiichi Sankyo Turkey

Last updated: 01.06.2015

Address: Kar Plaza Kayışdağı Cad. Karaman
Çiftlik Yolu No:47 E Blok Kat:3
34752 İçerenköy / Kadiköy – İstanbul

Tel: +90 216 5776505

Web: http://www.daiichi-sankyo.com.tr/

Company description

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. (DSI) draws on a rich heritage of innovation, integrity and accountability. While the success of our medicines speaks for itself, our corporate mission defines our vision and purpose.
To enrich the quality of life around the world through the development of innovative pharmaceuticals.
How do we bring this corporate mission to life? By bringing together medical and scientific expertise, a collaborative and ethical culture, and a robust pipeline. At Daiichi Sankyo, innovation is more than a corporate motto. It’s a philosophy we put into practice each and every day.

Products and services

Together with our healthcare partners, Daiichi Sankyo is helping patients live healthier lives. Our
comprehensive portfolio offers a wide range of treatments for patients in a number of disease
categories including hypertension, heart disease, diabetes and hyperlipidemia/atherosclerosis.

From the discovery of epinephrine (also known as adrenaline) in 1889, to the development of the statin class of lipid-lowering agents and the development of the first glitazone, which revolutionized long-term control of type 2 diabetes, our history of innovation continues to define our vision and purpose. With our scientific curiosity, willingness to examine new ideas and pairing of existing information with novel concepts, we create medicines as well as new methods of drug discovery and delivery.



We use cookies to ensure that we give you the best experience on our site. For more info click here